Artificial Solutions - Looming capital raise in focus despite a strong report
2022-10-20 08:46:00
Redeye raises its estimates on the back of a strong Q3 2022 report, which beat expectations and provided some bullish financial targets. However, we lower our fair value range due to the uncertainty regarding Artificial Solutions’ near-term capital constraints.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.